The Epidermal Growth Factor Receptor Inhibitor-Related Skin Toxicity Index (EGFRISTI): A New Tool for Grading and Managing Skin Adverse Reactions to Epidermal Growth Factor Receptor Inhibitors

By  

Oncology, Vol. 87, Iss. 5, 2014-08 ,pp. : 311-319

Karger

Access to resources Recommend Favorite

Treatment of Epidermal Growth Factor Receptor Antagonist-Induced Skin Rash: Results of a Survey among German Oncologists

By  

Oncology Research and Treatment, Vol. 33, Iss. 3, 2010-02 ,pp. : 94-98

Karger

Access to resources Recommend Favorite

Impact and Management of Skin Toxicity Associated with Anti-Epidermal Growth Factor Receptor Therapy: Survey Results

By  

Oncology, Vol. 72, Iss. 3-4, 2007-12 ,pp. : 152-159

Karger

Access to resources Recommend Favorite

Identification of mRNA‐Rich Keratinocytes in the Basal/Suprabasal Layers of Psoriatic Skin

By  

THE JOURNAL OF DERMATOLOGY, Vol. 23, Iss. 12, 1996-12 ,pp. : 858-862

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical outcome according to the level of preexisting epidermal growth factor receptor T790M mutation in patients with lung cancer harboring sensitive epidermal growth factor receptor mutations

By  

CANCER, Vol. 120, Iss. 14, 2014-07 ,pp. : 2090-2098

John Wiley & Sons Inc

Access to resources Recommend Favorite